SCHEMBL6949202

SCHEMBL6949202

C=CCn1c(NCCOc2ccccc2)nc(N2CCc3ccccc3CC2)c(C#N)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.37
MAPT P10636 8/20 0.37
KDM4E B2RXH2 8/20 0.37
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
HIF1A Q16665 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KLK7 P49862 1/20 0.37
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HTT P42858 5/20 0.35
LMNA P02545 3/20 0.35
MAPK1 P28482 1/20 0.35
AURKA O14965 1/20 0.35
HPGD P15428 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952663 0.97 ALDH1A1 (0.36) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6948222 0.88 MAPT (0.39) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6950841 0.85 ALDH1A1 (0.45) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6950036 0.84 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6950993 0.84 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6954163 0.83 MAPT (0.39) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6947679 0.82 MAPT (0.39) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6951063 0.78 PDE4A (0.43) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6951049 0.78 MAPT (0.41) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6951375 0.77 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed